ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 664 out of 6969

$484K Total Retail Price of All Prescriptions

Rank: 634 out of 6969

509 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 380 295 S3 1 3
SIMVASTATIN 343 331 2 1
LEVOTHYROXINE SODIUM 343 284 2 5
LISINOPRIL 285 237 4 2
OMEPRAZOLE 225 178 5 6
AMLODIPINE BESYLATE 209 196 6 4
LOSARTAN POTASSIUM 145 140 7 12
METFORMIN HCL 144 107 8 7
ZOLPIDEM TARTRATE 140 101 9 16
FUROSEMIDE 139 132 10 10
HYDROCHLOROTHIAZIDE 124 113 11 8
GABAPENTIN 116 88 12 17
ATORVASTATIN CALCIUM 102 100 13 11
METOPROLOL SUCCINATE 101 86 14 22
WARFARIN SODIUM 101 86 14 20
CITALOPRAM HBR 97 80 16 34
ATENOLOL 91 78 17 9
POTASSIUM CHLORIDE 90 73 18 30
MORPHINE SULFATE ER 86 38 S2 19 90
LEVOXYL 83 69 20 122
SERTRALINE HCL 75 49 21 38
ALLOPURINOL 73 73 22 35
CYMBALTA 72 39 23 72
AZITHROMYCIN 69 59 24 42
AMOX TR-POTASSIUM CLAVULANATE 67 54 25 194
RAMIPRIL 66 65 26 112
TAMSULOSIN HCL 63 52 27 23
CARVEDILOL 63 58 27 25
PRAMIPEXOLE DIHYDROCHLORIDE 63 56 27 227
DILTIAZEM 24HR ER 62 48 30 183
CRESTOR 60 56 31 39
TRIAMTERENE-HCTZ 59 59 32 58
SPIRONOLACTONE 58 58 33 102
TOPIRAMATE 58 0 33 217
ADVAIR DISKUS 58 43 33 45
SPIRIVA 56 46 36 66
PREDNISONE 56 54 36 70
PRAVASTATIN SODIUM 54 43 38 19
HYDROMORPHONE HCL 53 0 S2 39 188
LANTUS 53 40 39 50
MIRTAZAPINE 53 34 39 76
FLUOXETINE HCL 53 41 39 43
BENAZEPRIL HCL 53 53 39 18
TRAMADOL HCL 53 51 39 27
ESCITALOPRAM OXALATE 52 44 45 93
NAMENDA 52 42 45 51
FLUTICASONE PROPIONATE 51 48 47 24
CLOPIDOGREL 50 50 48 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.